Description
WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.
WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.
BEST REGARDS
ERDAL CAN ALKOCLAR & METEHAN YESIL
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| A COMPOSITION FORMED FOR ENURESIS TREATMENT | Doc | Open resource | |
| A COMPOSITION FOR THE ANTI-INFLAMMATORY AND ANALGESIC TREATMENT | Docx | Open resource | |
| THE USE OF 2,3-TETRAHYDROBENZO[B][1,4]TRIOXIN-5,6-YL]CHROMAN-4-TRIONE AND DERIVATIVES FOR SYMPTOMATIC TREATMENT OF EPILEPSY | Doc | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS | Docx | Open resource | |
| 2- USING [(4-FLUOROETHYL)SULFONYL]DIHYDROPYRROLO[5,6-A]PYRAZINE-4(2H)-DIONE AND ITS ANALOGUES FOR DEMENTIA AND DERIVATIVES | Docx | Open resource | |
| A HYPOTHERMIC COMPOSITION | Docx | Open resource | |
| A COMPOSITION ABOUT THE TREATMENT OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS | Doc | Open resource | |
| A COMPOSITION FOR TREATING SPINAL CORD INJURY | Doc | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF B CELL DEFICIENCY | Docx | Open resource | |
| A NOOTROPIC COMPOSITION | Doc | Open resource | |
| A COMPOSITION FOR PREVENTING AND TREATING OBESITY | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY 1.1 | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY | Docx | Open resource | |
| A COMPOSITION PREPARED FOR THE TREATMENT OF OLFACTORY NERVE NEUROPATHY | Docx | Open resource | |
| A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS | Doc | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF TRIGEMINAL NEURALGIA | Docx | Open resource | |
| A COMPOSITION FOR PREVENTING GERIATRIC CACHEXIA | Docx | Open resource | |
| A COMPOSITION FOR TREATMENT OF DEPRESSION | Doc | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ANDROPAUSE | Docx | Open resource | |
| A COMPOSITION PREPARED FOR THE TREATMENT OF ALS | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF PARKINSON’S DISEASE | Docx | Open resource | |
| USE OF 3,7-BIS(2-HYDROXYETHYL)-3,5-TRIHYDROXY-2-(4-EPOXYPHENYL)-8-(3-METHYL-2-BUTEN-1-YL)-4H-1-BENZOPYREN-4-ONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF OSTEOPOROSIS | Docx | Open resource | |
| A COMPOSITION FOR USE IN THE TREATMENT OF ALCOHOL ADDICTION | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ARTHROPATHY DERIVATIVES | Docx | Open resource | |
| A PROTOPANAXTRIOL COMPOSITION FOR THE TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | Docx | Open resource | |
| A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF ARTHROSIS | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ACHONDROPLASIA AND GENERAL DEVELOPMENT DISORDERS | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF MALIGNANT TUMORS | Docx | Open resource | |
| A COMPOSITION FOR ANTIVIRAL USE | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF NECROSIS | Docx | Open resource | |
| A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF MS AND ALS DISEASES | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF TURNER SYNDROME | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF SARCOPENIA | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF NEUROENDOCRINAL DAMAGE CAUSED BY AUTOIMMUNE DISEASES | Docx | Open resource | |
| A COMPOSITION FOR REDUCING INSULIN DEPENDENCE IN THE TYPE 1 DIABETES DISEASE | Docx | Open resource | |
| A COMPOSITION FOR INCREASING THE SPEED OF WOUND HEALING | Docx | Open resource | |
| A COMPOSITION FOR USE IN THE TREATMENT OF SUBSTANCE DEPENDENCE | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ASTHENIA | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF MYASTHENIA | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS 1.1 | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS | Docx | Open resource | |
| A COMPOSITION FOR TREATING HEART ASTHENIA | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF IMMUNODEFICIENCY | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF HYPOTHYROIDISM | Docx | Open resource | |
| A COMPOSITION FOR INCREASING ATHLETIC PERFORMANCE | Docx | Open resource | |
| A COMPOSITION FOR SUPPORTING THE HEALING PROCESS OF THE WOUNDS AND GENERAL TISSUE DAMAGES | Docx | Open resource | |
| A SOMATOTROPIC AND PRO-THYROGENIC COMPOSITION FORMED FOR TREATING GROWTH/DEVELOPMENT/DWARFISM SYNDROMES | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF OBESITY | Docx | Open resource | |
| A HYPOTHERMIC, HYPOTENSIVE AND HYPOLIPIDEMIC COMPOSITION | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ALLERGIC REACTIONS | Docx | Open resource | |
| A COMPOSITION PROMOTING DENTINE FORMATION | Docx | Open resource | |
| A COMPOSITION FOR INCREASING THE PRODUCTION AND EXPRESSION OF NERVE GROWTH FACTOR | Docx | Open resource | |
| A COMPOSITION FOR ACCELERATING THE WOUND HEALING IN DIABETIC PATIENTS | Docx | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF CHRONIC BREAD | Doc | Open resource | |
| A COMPOSITION FOR TREATING THE MUSCLE WEAKNESS AND THE LOSS OF MUSCLE MASS FOLLOWING CHRONIC STROKE AND COMA | Docx | Open resource | |
| A FORMULATION INTENDED FOR THE TREATMENT OF PARKINSON’S DISEASE | Doc | Open resource | |
| A COMPOSITION FOR TREATING ANXIETY AND DEPRESSION | Docx | Open resource | |
| A COMPOSITION FOR THE TREATMENT OF ATTENTION AND CONCENTRATION DEFICIT DISORDERS | Docx | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF CROHN’S DISEASE | Doc | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF INTESTINAL MALABSORPTION | Doc | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF RENAL FAILURE | Doc | Open resource | |
| AN ADJUVANT COMPOSITION INTENDED FOR TREATMENT OF LEUKEMIA | Doc | Open resource | |
| AN ADJUVANT FORMULATION PREPARED FOR SYMPTOMATIC TREATMENT OF SCHIZOPHRENIA | Docx | Open resource | |
| A FORMULATION DEVELOPED FOR TREATMENT OF SUBSTANCE ADDICTION | Docx | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF MALARIA | Docx | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF CHOLERA | Docx | Open resource | |
| A FORMULATION INTENDED FOR ADJUVANT TREATMENT OF AIDS | Docx | Open resource | |
| FORMULATION INTENDED FOR TREATMENT OF HYPO-ADRENALISM | Docx | Open resource | |
| A FORMULATION INTENDED TO SLOW DOWN THE PROGRESS OF CANCER | Docx | Open resource | |
| A FORMULATION INTENDED TO HAVE ANTI-CARCINOGENIC EFFECT BY STIMULATING BAX EXPRESSION | Docx | Open resource | |
| A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT BY İTS BCL2 SUPPRESSİNG FUNCTİON | Docx | Open resource | |
| A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT VIA MEK SUPPRESSIVE FEATURES | Docx | Open resource | |
| A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY ITS NF-KAPPA B SUPPRESSION CAPABILITY | Docx | Open resource | |
| A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING GLYCOPROTEIN CD44 AND CXC CHEMOKINE RECEPTOR-4 (CXCR4) EXRESSIONS | Docx | Open resource | |
| A FORMULATION INTENDED TO SUPPRESS MMP-9 SECRETION AND RELEASE | Docx | Open resource | |
| A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT WITH ITS NADH OXIDASE SUPPRESSION CAPABILITY | Docx | Open resource | |
| A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY AURORA A KINASE PHOSPHORILATON SUPPRESSION | Docx | Open resource | |
| A FORMULATION INTENDED TO SUPPRESS THE CDC25 PHOSPHATASE AND CDC/2 CYCLINE B KINASE ACTIVITIES | Docx | Open resource | |
| A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT WITH HIF-1 ALPHA SUPPRESSION | Docx | Open resource | |
| A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING VCAM-1 EXPRESSION WHICH IS TRIGGERED BY TNF-A | Docx | Open resource | |
| A FORMULATION DISPLAYING ANTI-MITOTIC EFFECT BY SUPPPRESSING CDK-1 CDK-2 AND CYCLINE B1 EXPRESSION | Docx | Open resource | |
| A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING TYROSİNASE, (TRP-1) AND MITF PROTEINS’ EXPRESSION AND FUNCTION | Docx | Open resource | |
| AN ANTI-CARCINOGENIC ADJUVANT FORMULATION THAT FUNCTIONS BY SUPPRESSING G1/S PHASE SPECIFIC PROTEIN, CYCLINE D1 AND ANTI-APOPTOTIC BCL-XL PROTEIN EXPRESSION | Docx | Open resource | |
| A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING NESTIN EXPRESSION | Docx | Open resource | |
| A FORMULATION INTENDED FOR TREATMENT OF TYPE 1 DIABETES | Docx | Open resource | |
| A FORMULATION CONSISTING OF SYMPLOSOSIDE DERIVATIVES INTENDED TO SUPPRESS NUCLEOSIDE REVERSE TRANSCRIPTASE | Docx | Open resource | |
| A FORMULATION COMPRISING OF SYMPLOSOSIDE DERIVATIVES THAT ARE CHARACTERIZED BY TRIGGERING ENDOGENOUS PROTEIN KINASE PKR AND RNASE L EXPRESION | Docx | Open resource | |
| A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FORMED FOR SUPPRESSING DNA POLYMERASE | Docx | Open resource | |
| A COMPOSITION COMPRISING THE ANTIVIRAL COMPONENTS FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE | Docx | Open resource | |
| A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FOR SUPPRESSING DNA GYRASE | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-OBESITY ACTION FORMED FOR SUPPRESSING 5-LIPOOXYGENASE | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION FORMED FOR SUPPRESSING TYROSINE KINASE | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-NOCICEPTIVE ACTION FORMED FOR SUPPRESSING PGE2 EXPRESSION | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION FORMED FOR SUPPRESSING H3K27 METHYLTRANSFERASE | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-CARCINOGENIC SİMPLORASEMOSİT DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PHOSPHATIDYL 3-KINASE EXPRESSION | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION WITH THE CHARACTERISTIC OF SUPPRESSING THE GL1 EXPRESSION | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-VIRAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING NEUROAMINIDASE | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC PİCRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA TOPOISOMERASE | Docx | Open resource | |
| A COMPOSITION COMPRISING SYMPLORACEMOSİDE ANALOGUES THAT EXHIBIT ANTI-VIRAL ACTION WITH THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC METHYLPROTOBIOCIDE DERIVATIVES THAT EXHIBIT ANTI-VIRAL ACTION | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-VIRAL METHOXYSORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RIBONUCLEOTIDE REDUCTASE | Docx | Open resource | |
| A COMPOSITION COMPRISING PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HEMAGGLUTININ ESTERASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC PICRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA GYRASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS | Docx | Open resource | |
| A COMPOSITION COMPRISING SYMPLORACEMOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE AND THE USE OF THIS COMPOSITION AS ANTI-VIRAL TREATMENT | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-VIRAL ACTION | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA LIGASE | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION WITH THE CHARACTERISTIC OF SUPPRESSING NF-KAPPA B | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-BACTERIAL PSEUDO-PROTOBIOCIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING CYTOCHROME C PEROXIDASE | Docx | Open resource | |
| A COMPOSITION COMPRISING NOVEL İZOTERİSİN DERIVATIVES THAT EXHIBIT ANTI-BACTERIAL CHARACTERISTIC | Docx | Open resource | |
| A COMPOSITION COMPRISING CHALCOCITE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING BACTERIAL TERPENE SYNTHASE | Docx | Open resource | |
| A COMPOSITION COMPRISING OXYDERRICIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA LIGASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF BACTERIAL INFECTIONS | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING EPOXIDE HYDROLASE | Docx | Open resource | |
| A COMPOSITION COMPRISING NOVEL SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PEPTIDOGLYCAN HYDROLASE | Docx | Open resource | |
| A COMPOSITION CONSISTING OF SYNTHETIC PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYL TRANSFERASE | Docx | Open resource | |
| A COMPOSITION CONTAINING SYNTHETIC COMPONENTS FORMED FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE | Docx | Open resource | |
| A COMPOSITION COMPRISING BIOFLAVONOL GLYCOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING OSTEONECROSIS | Docx | Open resource | |
| A COMPOSITION COMPRISING MYOTROPIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOAMINE OXIDASE B | Docx | Open resource | |
| A COMPOSITION CONTAINING PSEUDOBIOCIDE DERIVATIVES THAT EXHIBIT GABAA RECEPTOR ANTAGONISTIC CHARACTER AND THE THEREOF USE FOR MYOTROPIC PURPOSE | Docx | Open resource | |
| A COMPOSITION CONTAINING PICRORETINE DERIVATIVES THAT TRIGGER THE ENDOGENOUS PHENETHYLAMINE PRODUCTION AND THE USE THEREOF FOR NOOTROPIC PURPOSE | Docx | Open resource | |
| A COMPOSITION CONTAINING PYRANOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF TRIGGERING AN INCREASE IN THE ACTIVITY OF AROMATIC AMINO ACID DECARBOXYLASE AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF DOPAMINERGIC DEFECTS | Docx | Open resource | |
| A COMPOSITION CONTAINING PICRORETOSIDE DERIVATIVES THAT EXHIBIT PRO-DOPAMINERGIC CHARACTER FOR INCREASING THE SENSITIVITY OF DOPAMINE 5 RECEPTOR | Docx | Open resource | |
| A COMPOSITION COMPRISING TRICYCLOPENTAONE DERIVATIVES THAT SUPPORT THE INCREASE OF THE MUSCLE STRENGTH BY MEANS OF AN INCREASE IN THE SENSITIVITY OF MUSCLE-SPECIFIC KINASE RECEPTOR | Docx | Open resource | |
| A COMPOSITION COMPRISING ANABOLIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF PROMOTING THE AGRIN EXPRESSION | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-CARCINOGENIC PROTOSPINOL DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HYPOXIA-INDUCIBLE FACTOR (HIF) 1-ALPHA | Docx | Open resource | |
| A COMPOSITION COMPRISING SORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING H3K27 METHYLATION | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK | Docx | Open resource | |
| A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PI3-KINASE ALPHA | Docx | Open resource | |
| A COMPOSITION COMPRISING LIPOLYTIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOCYTE CHEMOATTRACTANT PROTEIN-1 | Docx | Open resource | |
| A NEUROTROPHIC COMPOSITION | Docx | Open resource | |
| AN ANTIVIRAL COMPOSITION | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HIF PROLYL HYDROXYLASE AND THE USE OF THIS COMPOSITION AS AN ADJUVANT CANCER THERAPY | Docx | Open resource | |
| A COMPOSITION consisting of ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE Characteristic OF Suppressing dnaB Helicase | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER | Docx | Open resource | |
| A COMPOSITION COMPRISING SYNTHETIC PROTOBIOSIDE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER | Docx | Open resource | |
| A COMPOSITION COMPRISING PICRORETINE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF HIGH CHOLESTEROL | Docx | Open resource | |
| A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CANCER CHARACTER BY SUPPRESSING THE BCL-2 EXPRESSION | Docx | Open resource | |
| TR201304603 WIPO PATENT NOVELTY REPORT | Open resource | ||
| TR201304493 WIPO NOVELTY REPORT | Open resource | ||
| TR201305054 WIPO PATENT NOVELTY REPORT | Open resource | ||
| TR201305306 WIPO NOVELTY REPORT | Open resource | ||
| TR201305730 WIPO NOVELTY REPORT | Open resource | ||
| A COMPOSITION FOR PROMOTING TISSUE RENEWAL | Docx | Open resource | |
| A COMPOSITION PROMOTING HEPATIC AND INTESTINAL TISSUE RENEWAL | Docx | Open resource |
Tags
- anti-asthenic
- antibacterial
- anti-dementia
- antifungal
- anti-infective
- anti-inflammatory
- anti-pyretic
- antiviral
- bioceutical-innovations
- cancer
- crohns-disease
- dhea
- diabetes
- health
- hypertension
- immunomodulation
- myotrophic
- neuro-endocrinal
- neuromascular-optimization
- neurotransmission-enhancement
- procholinergic
- pro-dopaminergic
- sante
- thyrogenic